Withdrawal syndrome, discontinuation syndrome and rebound effect in the treatment with selected drug classes
Pharmacotherapy in Psychiatry and Neurology · 2025 · 41 (2) · 141-155
DOI: 10.5114/fpn.2025.159504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacotherapy in Psychiatry and Neurology, 2025. Verfasst von Barbara Sobera und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sobera, B., Gadzała, M., Mikołajczak, P., & Mirowska-Guzel, D. (2025). Withdrawal syndrome, discontinuation syndrome and rebound effect in the treatment with selected drug classes. Pharmacotherapy in Psychiatry and Neurology, 41(2), 141-155. https://doi.org/10.5114/fpn.2025.159504
Vancouver
Sobera B, Gadzała M, Mikołajczak P, Mirowska-Guzel D. Withdrawal syndrome, discontinuation syndrome and rebound effect in the treatment with selected drug classes. Pharmacotherapy in Psychiatry and Neurology. 2025;41(2):141-155. doi:10.5114/fpn.2025.159504
BibTeX
@article{Sobera2025,
author = {Sobera, Barbara and Gadzała, Mateusz and Mikołajczak, Przemysław and Mirowska-Guzel, Dagmara},
title = {Withdrawal syndrome, discontinuation syndrome and rebound effect in the treatment with selected drug classes},
journal = {Pharmacotherapy in Psychiatry and Neurology},
year = {2025},
volume = {41},
number = {2},
pages = {141--155},
doi = {10.5114/fpn.2025.159504}
}
EUVIMED